Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
27.01
+2.61 (10.70%)
Apr 8, 2026, 10:14 AM EDT - Market open
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.63 billion as of April 8, 2026. Its market cap has increased by 20,092.30% in one year.
Market Cap
1.63B
Enterprise Value
1.21B
1-Year Change
20,092.30%
Ranking
Category
Stock Price
$27.01
Market Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.63B, an increase of 341.67%. That is a compound annual growth rate of 31.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 1.47B | 3,903.33% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 1.60B |
| Oculis Holding AG | 1.58B |
| MBX Biosciences | 1.57B |
| Immunocore Holdings | 1.56B |
| Intellia Therapeutics | 1.55B |
| Nanobiotix | 1.53B |
| Trevi Therapeutics | 1.53B |
| Nuvation Bio | 1.51B |